Bruker Corporation (NASDAQ: BRKR) today reported financial results for its first quarter ended March 31, 2015. Bruker’s revenues for the first quarter of 2015 were $353.5 million, a decline of 16.6 percent compared to the first quarter of 2014. Excluding a 2.6 percent net negative effect from acquisitions & divestitures, and an 11.0 percent negative effect […]
WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc., (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company has completed its acquisition of Perten Instruments Group AB. More details HERE
Hamamatsu Photonics K.K. has announced the establishment of a new wholly-owned subsidiary, Hamamatsu Photonics Taiwan Co., Ltd., to enhance its sales support for distributors to Taiwan. The new subsidiary will be responsible for the import and export of components and other products, local inventory, and sales contracts. For further details click here.
Jena (Germany)/New Delhi (India), November 6, 2014 — Analytik Jena AG has established its own subsidiary in India, AJ Instruments India Pvt. Ltd., in order to strengthen its presence in the Indian market. The subsidiary is based in New Delhi, from where the Company will serve the customers of its largest business unit, Analytical […]
“Our strong fourth quarter and fiscal year 2014 results mark the conclusion of another successful year for the Company,” said Vincent A. Forlenza, Chairman, CEO and President. “Organic revenue growth continued to accelerate and we delivered a higher quality of earnings while maintaining our ongoing investments to support our innovation strategy. We have built […]
FEI Company (Nasdaq:FEIC) reported results for third quarter of 2014. Revenue of $227.8 million was up 4.2% compared to $218.5 million in the third quarter of 2013 and down 3.9% compared to $237.0 million in the second quarter of 2014. Net bookings in the third quarter were $250.1 million with a book-to-bill ratio of […]
Pacific Biosciences of California, Inc. (Nasdaq:PACB) today reported a 178% increase in revenue to $20.6 million for the third quarter ended September 30, 2014, compared to $7.4 million for the third quarter of 2013. Third quarter 2014 revenue included the achievement of the $10.0 million milestone related to Roche along with the $1.7 million quarterly amortization from the upfront Roche payment in addition to […]
“We’re pleased to extend our long track record of consistently delivering strong adjusted EPS growth,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “We leveraged our solid top-line results and our culture of operational discipline to achieve excellent performance on the bottom line. I’m also pleased to report that […]
Waters Corporation (NYSE:WAT) reported today third quarter 2014 sales of $493 million, an increase of 8% versus sales of $457 million in the third quarter of 2013. In the quarter, the effect of foreign currency translation was neutral to sales growth. On a GAAP basis, earnings per diluted share (EPS) for the third quarter were $1.34 compared to $1.14 for the third […]
Agilent Technologies Inc. (NYSE:A) today announced it is exiting its Nuclear Magnetic Resonance business. Agilent entered the NMR business in 2010, with the acquisition of Varian. Since then, the business has not met growth and profitability objectives. Agilent will stop taking new NMR system orders immediately, but the company will continue to meet customer commitments for orders in progress […]
BD Becton, Dickinson and Company NYSE: BDX, a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing NGS to genotyping for agricultural applications. For further details […]
Oxford Instruments plc, a leading provider of high-technology tools and systems for industry and research, is pleased to announce the appointment of Professor Sir Richard Friend as an Independent Non-Executive Director. The appointment takes effect from 1 September 2014. Professor Sir Richard Friend is a Fellow of the Royal Society and Fellow of the […]